Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05742217
Status:
RECRUITING
Last Update Posted:
2024-02-20
First Post:
2023-02-15
Brief Title:
A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma TCR-MM Are Treated in Italian Centers for Blood Related Diseases
Sponsor:
Pfizer
Organization:
Pfizer